 |
 | Vissza |
Szász Róbert; Altai Elvira; Pál Katalin; Dombi János Péter; Iványi János; Jakucs János; Jóni Natália; Illés Árpád; Tárkányi Ilona; Szerafin László; Nagy Zsolt; Farkas Péter; Nagy Ágnes; Piukovics Klára; Ujj György; Schneider Tamás:
Effectiveness of the Combination of Rituximab and Standard Chemotherapeutic Regimens in Previously Untreated Patients with Chronic Lymphocytic Leukaemia in Real-Life.
PATHOLOGY AND ONCOLOGY RESEARCH, 25 (2).
pp. 535-540.
ISSN 1219-4956
(2019)
Tolnay Edina; Ghimessy Áron; Juhász Erzsébet; Sztancsik Zsuzsanna; Losonczy György; Dombi János Péter; Vennes Zsuzsanna; Helf László; Csada Edit; Sárosi Veronika:
The efficacy and safety of bevacizumab in addition to platinum-based chemotherapy for the first-line treatment of patients with advanced nonsquamous non-small-cell lung cancer : Final results of AVALANCHE, an observational cohort study.
ONCOLOGY LETTERS, 17 (2).
pp. 1750-1760.
ISSN 1792-1074
(2019)
Schneider Tamás; Rosta András; Losonczy Hajna; Radványi Gábor; Ujj György; Egyed Miklós; Illés Árpád; Jakucs János; Szerafin László; Gasztonyi Zoltán; Masszi Tamás; Iványi János; Demeter Judit; Dombi János Péter; Tóth Antal; Borbényi Zita:
Efficacy and Tolerability of a 2-Year Rituximab Maintenance Therapy in Patients with Advanced Follicular Lymphoma after Induction of Response with Rituximab-Containing First Line-Regimens (HUSOM Study).
PATHOLOGY AND ONCOLOGY RESEARCH, 24 (2).
pp. 199-205.
ISSN 1219-4956
(2018)
